FDA adds warning to J&J COVID-19 vaccine over links to rare autoimmune disorder – By Darryl Coote (UPI) / July 13 2021
July 13 (UPI) — The U.S. Food and Drug Administration announced a new warning for the Johnson & Johnson COVID-19 vaccine over its association with an increased risk of Guillain-Barre syndrome, a rare autoimmune disorder where the immune system damages the nerve cells.
The FDA announced the update to the one-shot jab on Monday in a letter to the company as well as in amendments to its fact sheets on the vaccine in response to new data showing cases of people displaying symptoms of the syndrome within 42 days of receiving the shot.
The warning states: “Reports of adverse events following use of Janssen COVID-19 Vaccine under emergency use authorization suggest an increased risk of Guillain-Barre syndrome during the 42 days following vaccination.”
Janssen is a subsidiary of Johnson & Johnson.
